Neil Skolnik, MD
Professor of Family and Community Medicine
Temple University School of Medicine
Associate Director, Family Medicine Residency Program
Abington Jefferson Health
Jenkintown, PA
Professor of Family and Community Medicine
Temple University School of Medicine
Associate Director, Family Medicine Residency Program
Abington Jefferson Health
Jenkintown, PA
Related Videos
- ARS-Based, Interactive Session Focused on a Patient with T2D Who Has a High Risk for Hypoglycemia, is Overweight, and Despite Basal Insulin Therapy Plus Metformin and an SGLT-2 Inhibitor, and has Significantly Elevated Post-Prandial Glucose Levels.
All Basal Insulins Are Not Created Equal - Neil Skolnik, MD, FACE
Comparative PK/PD, Efficacy, Side Effect (Nocturnal Hypoglycemia), and Safety Profiles for Established and New, Longer-Acting Basal Insulins: An Evidence- and Trial-Based Translational Roadmap for the Primary Care and Internal Medicine Specialist
PHYSIOLOGIC, BASAL INSULIN, INTERACTIVE (ARS) CASE MANGEMEMENT SESSION #2 - Neil Skolnik, MD, FACE
What is the Mechanistic Rationale for Early Initiation of a Physiologic, Basal Insulin in Vulnerable Patients Who Require Intensified Glycemic Control?
Interactive Q&A Session and Special “Hot Topics in T2D” Session Faculty Panel
Interactive Q&A Session and Special “Hot Topics in T2D” Session.